Novolog (Pharm-Up 1966) Ltd (TLV:NVLG)

Novolog (Pharm-Up 1966) Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	204.46	121.77	247.6	232.94	172.81	238.71
Cash & Short-Term Investments	204.46	121.77	247.6	232.94	172.81	238.71
Cash Growth	-6.42%	-50.82%	6.29%	34.80%	-27.61%	35.29%
Accounts Receivable	1,504	1,015	1,744	1,560	1,310	1,286
Other Receivables	52.86	42.42	46.62	53.43	36.54	20.28
Receivables	1,557	1,057	1,790	1,613	1,346	1,306
Inventory	294.13	250.78	315.08	247.33	189.03	186.79
Prepaid Expenses	-	9.89	7.57	11.35	9.56	10.25
Other Current Assets	1.37	53.16	8.25	1.86	0.76	-
Total Current Assets	2,057	1,493	2,369	2,106	1,719	1,742
Property, Plant & Equipment	257.71	271.4	297.54	321.4	306.62	224.77
Long-Term Investments	15.04	15.01	13.61	16.2	42.31	23.4
Goodwill	150.67	145.04	156.2	162.69	206.96	161.06
Other Intangible Assets	179	179.4	159.25	138.43	121.92	97.4
Long-Term Accounts Receivable	21.29	23.22	26.11	29.62	32.15	33.94
Long-Term Deferred Tax Assets	19.07	12.4	3.74	4.82	1.78	0.77
Other Long-Term Assets	6.37	8.36	11.85	9	6.29	5.04
Total Assets	2,706	2,148	3,037	2,789	2,437	2,289

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	2,054	1,486	2,357	2,079	1,662	1,616
Accrued Expenses	-	72.01	64.5	56.53	49.43	43.48
Current Portion of Long-Term Debt	-	-	-	0.91	1.15	0.39
Current Portion of Leases	17.35	25.2	21.31	26.6	22.06	20.14
Current Income Taxes Payable	2.7	7.59	6.03	6.55	6.52	4.59
Other Current Liabilities	110.93	20.84	13.66	15.65	13.42	4.3
Total Current Liabilities	2,185	1,612	2,462	2,185	1,754	1,689
Long-Term Debt	-	-	-	0.07	0.97	0.92
Long-Term Leases	153.84	158	177.16	187.59	188.6	145.37
Pension & Post-Retirement Benefits	1.25	1.46	1.41	1.88	2.01	3.75
Long-Term Deferred Tax Liabilities	6.74	7.71	12.94	16.41	19.71	17.63
Other Long-Term Liabilities	2.63	-	1.18	1.69	6.46	1.42
Total Liabilities	2,349	1,779	2,655	2,392	1,972	1,858

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	5.11	5.11	5.11	5.11	5.09	5.07
Additional Paid-In Capital	347.76	347.7	347.19	345.07	340.97	339.73
Retained Earnings	17.33	16.33	32.21	32.67	91.58	75.97
Comprehensive Income & Other	-19.28	-12.28	-16.13	-11.77	-1.93	3.61
Total Common Equity	350.91	356.85	368.38	371.08	435.7	424.37
Minority Interest	6.16	12.05	13.77	25.04	28.78	5.86
Shareholders' Equity	357.07	368.91	382.14	396.12	464.48	430.23
Total Liabilities & Equity	2,706	2,148	3,037	2,789	2,437	2,289

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	171.19	183.2	198.47	215.18	212.77	166.81
Net Cash (Debt)	33.27	-61.44	49.13	17.76	-39.97	71.9
Net Cash Growth	18.55%	-	176.64%	-	-	223.81%
Net Cash Per Share	0.07	-0.12	0.10	0.03	-0.08	0.14
Filing Date Shares Outstanding	510.88	510.87	510.75	510.72	508.7	506.57
Total Common Shares Outstanding	510.88	510.87	510.75	510.72	508.7	506.57
Working Capital	-127.62	-118.75	-93.45	-78.39	-35.81	52.94
Book Value Per Share	0.69	0.70	0.72	0.73	0.86	0.84
Tangible Book Value	21.24	32.42	52.93	69.97	106.82	165.91
Tangible Book Value Per Share	0.04	0.06	0.10	0.14	0.21	0.33
Machinery	-	104.94	145.73	148.01	131.88	155.63
Leasehold Improvements	-	129.52	134.68	131.41	113.03	74.47

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 1, 2026

Data Sources Report a data error